D.E. Shaw & Co’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.2M | Sell |
832,563
-692,964
| -45% | -$12.6M | 0.01% | 848 |
|
|
2025
Q1 | $30.3M | Sell |
1,525,527
-1,541,048
| -50% | -$30.6M | 0.03% | 509 |
|
|
2024
Q4 | $52.6M | Sell |
3,066,575
-2,197,520
| -42% | -$37.7M | 0.04% | 354 |
|
|
2024
Q3 | $105M | Sell |
5,264,095
-1,560,422
| -23% | -$31.2M | 0.09% | 160 |
|
|
2024
Q2 | $76.3M | Buy |
6,824,517
+1,442,799
| +27% | +$16.1M | 0.07% | 216 |
|
|
2024
Q1 | $35.5M | Sell |
5,381,718
-1,131,835
| -17% | -$7.47M | 0.03% | 388 |
|
|
2023
Q4 | $29.4M | Sell |
6,513,553
-1,058,140
| -14% | -$4.78M | 0.03% | 426 |
|
|
2023
Q3 | $27.1M | Sell |
7,571,693
-602,124
| -7% | -$2.16M | 0.03% | 439 |
|
|
2023
Q2 | $30.2M | Sell |
8,173,817
-37,756
| -0.5% | -$139K | 0.03% | 413 |
|
|
2023
Q1 | $27.2M | Sell |
8,211,573
-296,836
| -3% | -$983K | 0.03% | 468 |
|
|
2022
Q4 | $33M | Buy |
8,508,409
+2,664,613
| +46% | +$10.3M | 0.04% | 390 |
|
|
2022
Q3 | $14.2M | Buy |
5,843,796
+1,011,404
| +21% | +$2.46M | 0.02% | 727 |
|
|
2022
Q2 | $9.57M | Buy |
4,832,392
+2,930,104
| +154% | +$5.8M | 0.01% | 1007 |
|
|
2022
Q1 | $3.48M | Buy |
1,902,288
+1,812,981
| +2,030% | +$3.32M | ﹤0.01% | 2001 |
|
|
2021
Q4 | $126K | Buy |
+89,307
| New | +$126K | ﹤0.01% | 3610 |
|
|
2021
Q3 | – | Sell |
-211,692
| Closed | -$339K | – | 3601 |
|
|
2021
Q2 | $339K | Buy |
+211,692
| New | +$339K | ﹤0.01% | 3040 |
|
|
2020
Q4 | – | Sell |
-10,030
| Closed | -$24K | – | 2696 |
|
|
2020
Q3 | $24K | Buy |
+10,030
| New | +$24K | ﹤0.01% | 2540 |
|